Why it was recalled
Cross Contamination with Other Products
Product description
Nebivolol Tablets, 20 mg, 90 Tablets, Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh 454775, India, Manufactured for Avkare, Pulaski, TN 38478, Product of Italy, NDC 42291-874-90.
Lot numbers, UPCs & expiration codes
Lot# 17240988; Exp. 05/31/2026
Where it was sold
U.S. Nationwide
What to do if you have this product
- Compare the lot number and expiration date on your package with the codes above.
- Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
- If you have symptoms you think are related, contact your doctor. In an emergency call 911.
- Report side effects to FDA MedWatch at 1-800-FDA-1088.
Recall details
- Recall number
- D-0222-2026
- Classification
- Class III
- Status
- Ongoing
- Recall initiated
- Nov 18, 2025
- FDA report date
- Dec 17, 2025
- Quantity
- 672 90-count bottles
- Recall type
- Voluntary: Firm initiated
- Recalling firm
- Glenmark Pharmaceuticals Inc., USA
Original FDA data
Every field from FDA enforcement report D-0222-2026, exactly as published.
Show all FDA fields
- City
- Mahwah
- State
- NJ
- Status
- Ongoing
- Country
- United States
- Event ID
- 98014
- Address
- 750 Corporate Dr
- Code information
- Lot# 17240988; Exp. 05/31/2026
- Postal code
- 07430-2009
- Report date
- Dec 17, 2025
- Product type
- Drugs
- Recall number
- D-0222-2026
- Classification
- Class III
- Recalling firm
- Glenmark Pharmaceuticals Inc., USA
- Product quantity
- 672 90-count bottles
- Reason for recall
- Cross Contamination with Other Products
- Voluntary / mandated
- Voluntary: Firm initiated
- Product description
- Nebivolol Tablets, 20 mg, 90 Tablets, Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh 454775, India, Manufactured for Avkare, Pulaski, TN 38478, Product of Italy, NDC 42291-874-90.
- Distribution pattern
- U.S. Nationwide
- Recall initiation date
- Nov 18, 2025
- Initial firm notification
- Letter
- Center classification date
- Dec 9, 2025